April 7, 2016 | Israeli digital health startup Sweetch Health, which has developed a “digital vaccine” for diabetes, has raised $3.5 million in a Series A round led by OurCrowd, a leading equity crowdfunding platform, and Philips, a leading health technology company. Participation from prior investors also included Pontifax L.P. and Lionbird L.P. Sweetch Health has developed a revolutionary platform that assists in identifying individuals at risk of developing diabetes and coaching to prevent diabetes and other chronic conditions. Current funding will be used to complete a pilot program and clinical trials soon to begin at a major international medical institution and jump start commercialization in the USA. Upon completion, Sweetch will be well positioned to be “prescribed” by medical team personnel worldwide. Sweetch Health was founded in 2013 and is run by CEO Dana Chanan. Headquartered in Jerusalem, OurCrowd was founded in 2012 by Jon Medved.